Status: Recruiting
A Trial of Dyanavel XR in Treating Co-occurring Fatigue Symptoms in Adults With Attention Deficit Hyperactivity Disorder (ADHD).
The goal of this clinical trial is to study the impact of Dyanavel on co-occuring fatigue in adults with Attention Deficit/Hyperactivity Disorder. The main question it aims to answer is whether Dyanavel XR leads to a statistically significant reduction in fatigue compared to placebo, as measured by the Fatigue Symptom Inventory.
Participants needed: 50
Trial details
Phase: Phase 4Age: 18-65Biological sex: AllType: InterventionalSponsor: Rochester Center for Behavioral MedicineUpdated: Nov 21, 2024Locations: 1
Eligibility criteria
At screening, all subjects must have a Fatigue Symptom Inventory average score o... [+12]
Subjects must not be an immediate family of the Investigator or others directly... [+18]